Antiemetic prophylaxis regimens in haematologic malignancies patients undergoing a hematopoietic stem cell transplantation. Which is the best standard of care? A systematic review

Documents similaires

• Outcomes of older adults undergoing allogeneic hematopoietic cell transplantation with post‐transplant cyclophosphamide based prophylaxis
  par: Victoria Murillo, et autres
  Publié: (2024)
• Outcomes and risk factors of second allogeneic haematopoietic stem cell transplantation in patients with relapsed haematological malignancy after first transplantation
  par: Xiaolu Zhu, et autres
  Publié: (2025)
• The association of thrombocytopenia with haematological malignancy
  par: Abi Vijenthira, et autres
  Publié: (2026)
• Prior status of graft‐versus‐host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantation
  par: Claudia Mae Velasco, et autres
  Publié: (2025)
• Letermovir as secondary prophylaxis of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: A single center experience
  par: Nihar Desai, et autres
  Publié: (2024)